Suleyman Alici

Summary

Publications

  1. ncbi request reprint Prognostic factors and COX-2 expression in advanced stage esophageal squamous cell carcinoma
    Suleyman Alici
    Oncology Department, Medical School of Yuzuncu Yil University, Van, Turkey
    Adv Ther 23:672-9. 2006
  2. ncbi request reprint Low-dose docetaxel/cisplatin - leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinoma
    Suleyman Alici
    Oncology of Department of Goztepe Medical Park Hospital, Medical School of Bahcesehir University, Istanbul, Turkey
    Asian Pac J Cancer Prev 14:423-7. 2013
  3. ncbi request reprint Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma
    Suleyman Alici
    Department of Oncology, Medical School of Yuzuncu Yil University, Van, Turkey
    Med Sci Monit 12:CR221-9. 2006
  4. ncbi request reprint Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas
    Suleyman Alici
    Oncology Department, Private Goztepe Medical Park Hospital, Kanser Hospital Goztepe, Istanbul, Turkey
    Asian Pac J Cancer Prev 10:1051-5. 2009
  5. ncbi request reprint Isolated splenic metastases occurring as an unknown primary lesion
    S Alici
    Department of Medical Oncology, Yuzuncu Yil University, School of Medicine, Van 65200, Turkey
    J Postgrad Med 49:83-4. 2003
  6. ncbi request reprint Colorectal cancer in young patients: characteristics and outcome
    Suleyman Alici
    Institute of Oncology, University of Istanbul, Istanbul, Turkey
    Tohoku J Exp Med 199:85-93. 2003
  7. ncbi request reprint Prognostic factors in localized aggressive non-Hodgkin's lymphoma
    Suleyman Alici
    Institute of Oncology, Istanbul University, Istambul, Turkey
    Am J Clin Oncol 26:1-5. 2003
  8. ncbi request reprint Clinical characteristics of gestational trophoblastic disease at a single institute
    Suleyman Alici
    Institute of Oncology, Istanbul University, Turkey
    Tohoku J Exp Med 197:95-100. 2002
  9. doi request reprint Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens
    Ramazan Yildiz
    Department of Medical Oncology, Gazi University Medical School, Ankara, Turkey
    J Oncol Pharm Pract 16:173-8. 2010
  10. doi request reprint UFT plus oral folinic acid with alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes
    Ugur Coskun
    Department of Medical Oncology, Gazi University Medical School, Ankara, Turkey
    Onkologie 32:562-6. 2009

Detail Information

Publications23

  1. ncbi request reprint Prognostic factors and COX-2 expression in advanced stage esophageal squamous cell carcinoma
    Suleyman Alici
    Oncology Department, Medical School of Yuzuncu Yil University, Van, Turkey
    Adv Ther 23:672-9. 2006
    ..002) were independent prognostic factors. Results showed that in patients with ESCC, COX-2 overexpression was significantly correlated with visceral metastases IVM1b). COX-2 overexpression is an unfavorable prognostic factor in ESCC...
  2. ncbi request reprint Low-dose docetaxel/cisplatin - leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinoma
    Suleyman Alici
    Oncology of Department of Goztepe Medical Park Hospital, Medical School of Bahcesehir University, Istanbul, Turkey
    Asian Pac J Cancer Prev 14:423-7. 2013
    ..To reduce toxicity while maintaining the efficacy of DCF, we investigated low dose docetaxel (D), cispatin (C) - leucovorin and fluorouracil (De Gramont regimen)...
  3. ncbi request reprint Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma
    Suleyman Alici
    Department of Oncology, Medical School of Yuzuncu Yil University, Van, Turkey
    Med Sci Monit 12:CR221-9. 2006
    ..Prognosis in patients with gastric cancer is determined by the tumor itself, as well as certain patient-related factors...
  4. ncbi request reprint Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas
    Suleyman Alici
    Oncology Department, Private Goztepe Medical Park Hospital, Kanser Hospital Goztepe, Istanbul, Turkey
    Asian Pac J Cancer Prev 10:1051-5. 2009
    ..The availability of an intravenous (i.v.) and oral form of vinorelbine appeared as a particularly convenient way to provide a consolidation treatment to patients who have achieved an objective response or stable disease...
  5. ncbi request reprint Isolated splenic metastases occurring as an unknown primary lesion
    S Alici
    Department of Medical Oncology, Yuzuncu Yil University, School of Medicine, Van 65200, Turkey
    J Postgrad Med 49:83-4. 2003
  6. ncbi request reprint Colorectal cancer in young patients: characteristics and outcome
    Suleyman Alici
    Institute of Oncology, University of Istanbul, Istanbul, Turkey
    Tohoku J Exp Med 199:85-93. 2003
    ..However, in patients aged 40 years or younger, distal location of tumor and advanced stage should be considered as poor prognostic factors for overall survival...
  7. ncbi request reprint Prognostic factors in localized aggressive non-Hodgkin's lymphoma
    Suleyman Alici
    Institute of Oncology, Istanbul University, Istambul, Turkey
    Am J Clin Oncol 26:1-5. 2003
    ..These factors need to be evaluated for analyzing the outcome of treatment and to identify better therapeutic strategies...
  8. ncbi request reprint Clinical characteristics of gestational trophoblastic disease at a single institute
    Suleyman Alici
    Institute of Oncology, Istanbul University, Turkey
    Tohoku J Exp Med 197:95-100. 2002
    ..And, our report confirms that the alternating EMA/CO regimen is a well-tolerated and effective combination for the treatment of women with high-risk GTD...
  9. doi request reprint Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens
    Ramazan Yildiz
    Department of Medical Oncology, Gazi University Medical School, Ankara, Turkey
    J Oncol Pharm Pract 16:173-8. 2010
    ..In the present study, we determined the efficacy and the safety of docetaxel and oral etoposide as second-line combination chemotherapy after failure of commonly used combination regimens in AGC...
  10. doi request reprint UFT plus oral folinic acid with alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes
    Ugur Coskun
    Department of Medical Oncology, Gazi University Medical School, Ankara, Turkey
    Onkologie 32:562-6. 2009
    ..We retrospectively evaluated the activity and toxicity of uracil/tegafur (UFT) plus oral folinic acid in combination with vinorelbine (alternating intravenous (IV) on day 1 and oral on day 8) in patients with metastatic breast cancer...
  11. ncbi request reprint Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC)
    Suleyman Alici
    Institute of Oncology, University of Istanbul, Istanbul, Turkey
    Am J Clin Oncol 26:358-62. 2003
    ..Oral etoposide has considerable activity with a tolerable toxicity profile for the treatment of platinum-resistant epithelial ovarian cancer...
  12. ncbi request reprint Aggressive non-Hodgkin's lymphoma treated at the Institute of Oncology, Istanbul: treatment, outcome, and prognostic factors
    Suleyman Alici
    Institute of Oncology, Istanbul University, Istanbul, Turkey
    Am J Clin Oncol 25:502-8. 2002
    ..In multivariate analyses, patient age, performance status, and treatment response emerged as independent prognostic factors for survival...
  13. ncbi request reprint Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcoma
    Ali Osman Kaya
    Department of Medical Oncology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey
    Asian Pac J Cancer Prev 13:463-7. 2012
    ..To assess the safety and efficacy of a gemcitabine plus docetaxel regimen as a second line therapy for patients with advanced soft tissue sarcoma (STS) resistant to doxorubicin and ifosfamide-based therapy...
  14. doi request reprint Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy
    Ali O Kaya
    Department of Medical Oncology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey
    Onkologie 35:576-80. 2012
    ..We retrospectively evaluated the efficacy and toxicity of paclitaxel plus doxorubicin as a second-line treatment in patients with urothelial carcinoma, who had not responded to a prior platinum plus gemcitabine combination...
  15. ncbi request reprint Efficacy and toxicity of gemcitabine and pegylated liposomal Doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancer
    Aziz Karaoglu
    Department of Medical Oncology, Firat University, Elazig, Turkey
    Asian Pac J Cancer Prev 10:63-6. 2009
    ..In this study, we evaluated the efficacy and tolerability of the combination of gemcitabine and pegylated liposomal doxorubicin (PLD) in patients with platinum resistant/refractory ovarian cancer...
  16. ncbi request reprint Anemia in oncology practice: relation to diseases and their therapies
    Faruk Tas
    Institute of Oncology, University of Istanbul, Istanbul, Turkey
    Am J Clin Oncol 25:371-9. 2002
    ..The mechanisms underlying the propensity for a higher risk of pretreatment anemia in patients with malignant disorders and its influence on the outcome has to be elucidated by further population-based and molecular studies...
  17. ncbi request reprint Prognostic factors in patients with aggressive non-Hodgkin's lymphoma without complete response to first-line therapy
    Suleyman Alici
    Institute of Oncology, Istanbul University, Istanbul, Turkey
    Adv Ther 23:534-42. 2006
    ..009) and histologic grade (P=.001). Although prognosis is rather poor in patients with high histologic grade and primary refractory disease, patients with a PR have a slightly better prognosis...
  18. ncbi request reprint Clinicopathological features in bilateral breast cancer
    Meltem Baykara
    Department of Medical Oncology, Gazi University Medical Faculty, Ankara, Turkey
    Asian Pac J Cancer Prev 13:4571-5. 2012
    ....
  19. ncbi request reprint Incidence of renal insufficiency in cancer patients
    Ekrem Dogan
    Department of Internal Medicine, Yuzuncu Yil University, Van, Turkey
    Adv Ther 22:357-62. 2005
    ....
  20. ncbi request reprint Prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences
    Bala Basak Oven Ustaalioglu
    Department of Medical Oncology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey E mail
    Asian Pac J Cancer Prev 14:6287-92. 2013
    ..01, HR:0.57) and LVI (p=0.004, HR:0.57) for DFS. Conclusions: Although adjuvant chemotherapy is standard for early stage lymph node positive NSCLC, it has less clear importance in stage I and IIA patients without lymph node metastasis. ..
  21. ncbi request reprint Fatal lactic acidosis due to leukemic transformation in a patient with non-Hodgkin's lymphoma: case report
    Ekrem Dogan
    Division of Nephrology, Yuzuncu Yil University, Van, Turkey
    Adv Ther 22:443-6. 2005
    ..There was no reason other than leukemia-such as infection, circulatory failure, or drug use-for the development of severe LA. This case report shows that in patients with NHL, leukemic transformation may give rise to LA...
  22. pmc Coexistence of subacute thyroiditis and renal cell carcinoma: a paraneoplastic syndrome
    Ekrem Algun
    Department of Endocrinology, School of Medicine, Yuzuncu Yil University, Van, Turkey
    CMAJ 168:985-6. 2003
    ..We suggest that, in this patient, subacute thyroiditis manifested as a paraneoplastic syndrome of renal cell carcinoma...
  23. pmc The effect of high dose digoxin on cytokines in healthy dogs
    Haluk Dulger
    Department of Biochemistry, School of Medicine, University of Yuzuncu Yil, Tip Fakultesi, Biyokimya Anabilim Dali, Maras Caddesi, 65300 Van, Turkey
    Mediators Inflamm 11:261-3. 2002
    ..The drugs used to treat heart failure affect the production of cytokines. Digoxin, on which this study was focused, is one of the drugs for the treatment of heart failure...